Efficacy and safety of valbenazine in the treatment of cervical dystonia: a pilot study
BackgroundVesicular monoamine transporter-2 inhibitors have provided on-label success in the treatment of tardive dyskinesia (TD) and Huntington’s disease chorea (HDC). A similar pathophysiological pathway for cervical dystonia suggests valbenazine (VBZ) could be beneficial in this condition.Objecti...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Dystonia |
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/dyst.2025.13923/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|